阻塞性睡眠呼吸暂停综合征中的血清阿斯素水平:与疾病严重程度和脂肪组织分布的关系
Alperen Aksakal1, Buğra Kerget2,3, Hatice Beyza Özkan2
1Yakutiye Medical Research Center, Department of Pulmonary Medicine, Ataturk University, School of Medicine, Yakutiye, Erzurum, 25240, Turkey. alperennaksakal@hotmail.com.
Sleep & breathing = Schlaf & Atmung
|January 6, 2026
概括
阻塞性睡眠呼吸暂停综合征 (OSAS) 患者的血清阿斯素水平升高,与疾病严重程度和身体脂肪分布相关. 阿斯素显示出作为OSAS诊断和严重程度评估的生物标志物的潜力.
科学领域:
- 内分泌学 在内分泌学.
- 睡眠医学 睡眠医学
- 代谢障碍 代谢障碍 代谢障碍
背景情况:
- 阻塞性睡眠呼吸暂停综合征 (OSAS) 与炎症和代谢问题有关.
- 阿斯素是一种阿迪波金,在能量平衡和胰岛素抵抗中起作用.
- 了解阿斯素的作用可能为OSAS病理生理学提供新的见解.
研究的目的:
- 为了研究OSAS患者的血清阿斯素水平.
- 检查阿斯素水平与OSAS严重程度之间的相关性.
- 评估阿斯素与OSAS体脂分布之间的关系.
主要方法:
- 未来的,横截面的观察性研究.
- 包括接受多睡眠图 (PSG) 的患者.
- 排除具有混杂代谢条件的个体.
- 通过ELISA测量血清阿斯素,并测量脂肪分布的皮厚度.
主要成果:
- 与对照组相比,OSAS患者的血清阿斯素水平显著更高.
- 随着OSAS的严重程度 (更高的AHI),阿斯素水平增加.
- 观察到阿斯素水平与子周长,腹部,下和大腿皮肤之间存在积极的相关性.
结论:
- 在OSAS患者中,血清阿斯素水平升高.
- 阿斯素水平与OSAS的严重程度和身体脂肪分布相关.
- 亚斯素可以作为OSAS诊断和严重程度评估的潜在生物标志物.
相关概念视频
Sleep Apnea
469
Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
The condition is more prevalent among...
469
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
235
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
235
Drug Dosing: Obese Patients
217
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
217
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
165
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
165
Obesity
1.1K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K


